Project Grant R21MH139405
- Federal Project Grant Award Summary The National Institute on Minority Health and Health Disparities (NIMHD) awarded Kaiser Foundation Hospitals a $770,530 Project Grant on September 19, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct a mixed-methods implementation research study examining racial and ethnic disparities in depression treatment and outcomes across five health systems in seven states. The study will analyze factors contributing to...
- Federal Grant Award Summary Kaiser Foundation Hospitals (Kaiser Permanente) received a $1.422 million Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period of June 15, 2025 through May 31, 2028. The award supports the development and evaluation of a mobile health (mHealth) intervention designed to reduce substance use and HIV risk among young adult women affected by sex trafficking. The project will involve...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded a $3.24 million Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) to Kaiser Foundation Hospitals, effective June 1, 2025, through February 28, 2030. This research initiative comprehensively characterizes substance use disorder (SUD) care pathways and compares their quality and effectiveness using data from Kaiser Permanente Washington, a large integrated healthcare system. The study leverages...
- Federal Grant Award Summary The National Institute on Aging awarded a $627,916 Project Grant to Kaiser Foundation Hospitals (Kaiser Permanente) on September 15, 2025, under the Aging Research program (CFDA 93.866) to investigate missed home health care (HHC) in older adults with Alzheimer's disease and related dementias. This five-year study (completion date June 30, 2030) employs mixed methods research to identify key drivers and mitigators of missed HHC following hospital discharge,...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded a Project Grant of $191,117 to The Regents of the University of California, San Francisco under the Mental Health Research Grants program (CFDA 93.242) effective September 1, 2025, through August 31, 2030. This K23 award supports the development and pilot testing of PRISM-P (PrEP-Related Intervention for Stigma Mitigation among Pharmacy Staff), an anti-stigma intervention designed to improve personalized...
- Federal Grant Award Summary The Feinstein Institutes for Medical Research received a $1,659,568 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded June 2, 2025, with completion targeted for May 31, 2030. The award funds the ESPRITO EPINET project, which aims to expand a learning health system (LHS) framework for improving treatment outcomes in early first-episode psychosis (FEP) care. The project will enroll an...
- Federal Grant Award Summary Boston University Medical Campus received a $179,731 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), effective September 1, 2025 through August 31, 2030. This Mentored Research Scientist Development Award (K01) supports the development and preliminary testing of a pre-exposure prophylaxis (PrEP) decision aid to be delivered by community health workers in HIV testing clinics. The project...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded the University of Chicago a Project Grant of $819,998 under the Mental Health Research Grants program (CFDA 93.242) on August 6, 2025, with a completion date of May 31, 2030. The grant funds "Basic Income Guarantee Chicago: A Trial of Basic Income," a randomized controlled trial examining the impact of unconditional cash transfers on young people living with HIV (YPLWH). The primary deliverables include:...
- Federal Grant Award Summary The National Institute of Mental Health awarded a $733,314 Project Grant to The Johns Hopkins University on September 23, 2025, under the Mental Health Research Grants program (CFDA 93.242) to optimize measurement and evaluate health impacts of stigma among populations at risk for and living with HIV. The award supports a five-year research initiative (through August 31, 2030) designed to better characterize the effects of social, behavioral, and economic stigmas on...
- Federal Grant Award Summary The National Institute of Mental Health (NIMH) awarded Massachusetts General Hospital $183,118 under the Mental Health Research Grants program (CFDA 93.242) on September 1, 2025, for a four-year project extending through August 31, 2029. Dr. Tubbs will develop and validate clinical phenotyping algorithms that integrate genomic data with electronic health record (EHR) information to advance precision psychiatry. The project addresses three major gaps limiting genomic...
Kaiser Foundation Hospitals, operating through the Kaiser Foundation Research Institute in Washington, DC, received a $418,224 Project Grant from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242), awarded March 1, 2026, with completion targeted for February 29, 2028. The grant funds a mixed-methods research study examining medication adherence trajectories in older patients living with HIV (PLWH) who have multiple chronic conditions (MCCs), including Type 2 Diabetes, hypertension, and hyperlipidemia. This research addresses the growing clinical challenge of polypharmacy and suboptimal medication adherence as life expectancy increases for PLWH and co-morbid conditions become more prevalent. The research deliverables include a comprehensive taxonomy of composite medication adherence trajectories over a 36-month observation period for patients aged 50-99 years. The methodology combines group-based trajectory modeling (GBTM) of medication refill data with 75 semi-structured interviews to identify dynamic adherence profiles and understand the clinical, social, behavioral, cultural, structural, and economic factors influencing medication adherence decision-making. The resulting taxonomies and findings are intended to inform the development and testing of future medication adherence interventions and clinical decision support strategies designed to improve adherence-related outcomes in older PLWH with multiple chronic conditions.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $418.2k | 2/25/26 |